Paper Details

  1. Home
  2. Paper Details

Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder.

Author: BunnHannah, McCarthyBrian, MuzykAndrew, SantaluciaMorgan, SmithColin M, WilmouthCharlotte

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Dextromethorphan-bupropion (Auvelity) is a new, fast-acting, and well-tolerated treatment for major depressive disorder in adults. Clinical trials demonstrated significant reductions in depression severity scores and high remission and response rates.
Paper Details　
Original Abstract of the Article :
Depression is a significant cause of morbidity and mortality globally. Although various pharmacologic options exist for depression, treatments are limited by delayed or incomplete therapeutic response, low rates of remission, and adverse effects necessitating effective, fast-acting, and better toler...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591164/

データ提供：米国国立医学図書館（NLM）

A New Hope for Depression: Dextromethorphan-Bupropion

Depression is a widespread condition, casting a shadow on many lives. This review explores the efficacy and safety of dextromethorphan-bupropion (Auvelity), a newly approved treatment for major depressive disorder. It's like discovering a hidden oasis in the desert of mental health, offering a new source of relief and hope.

Clinical trials have shown that dextromethorphan-bupropion is effective in reducing depressive symptoms, with significant improvements seen within two weeks of treatment. It's like a refreshing spring in the desert, bringing quick and noticeable relief. The review highlights the potential of dextromethorphan-bupropion as a fast-acting and well-tolerated treatment for depression, offering a promising new option for those struggling with this condition.

A New Oasis of Hope

This research suggests that dextromethorphan-bupropion is a promising new treatment for depression, offering a faster and potentially more effective alternative to existing therapies. It's like discovering a new source of water in a parched desert, offering a new pathway to recovery.

Finding Relief

This research highlights the importance of seeking professional help for depression. It's like knowing where to find an oasis in the desert, seeking guidance and support when you need it most.

Dr.Camel's Conclusion

This review presents a hopeful new development in the treatment of depression. It's like finding a hidden oasis in the desert, offering a source of relief and a path towards a brighter future.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-10-25
Further Info :

Pubmed ID

37859435

DOI: Digital Object Identifier

PMC10591164

Related Literature

Article Analysis
・Effects of dextromethorphan and bupropion
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.